Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)

Detalles Bibliográficos
Autores principales: Zhao, Lin, Wang, Yan, Jiang, Longyang, He, Miao, Bai, Xuefeng, Yu, Lifeng, Wei, Minjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917747/
https://www.ncbi.nlm.nih.gov/pubmed/35279218
http://dx.doi.org/10.1186/s13046-022-02312-6
_version_ 1784668614842908672
author Zhao, Lin
Wang, Yan
Jiang, Longyang
He, Miao
Bai, Xuefeng
Yu, Lifeng
Wei, Minjie
author_facet Zhao, Lin
Wang, Yan
Jiang, Longyang
He, Miao
Bai, Xuefeng
Yu, Lifeng
Wei, Minjie
author_sort Zhao, Lin
collection PubMed
description
format Online
Article
Text
id pubmed-8917747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89177472022-03-21 Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1) Zhao, Lin Wang, Yan Jiang, Longyang He, Miao Bai, Xuefeng Yu, Lifeng Wei, Minjie J Exp Clin Cancer Res Correction BioMed Central 2022-03-12 /pmc/articles/PMC8917747/ /pubmed/35279218 http://dx.doi.org/10.1186/s13046-022-02312-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Zhao, Lin
Wang, Yan
Jiang, Longyang
He, Miao
Bai, Xuefeng
Yu, Lifeng
Wei, Minjie
Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
title Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
title_full Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
title_fullStr Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
title_full_unstemmed Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
title_short Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
title_sort correction to: mir-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing p-glycoprotein(p-gp) by targeting map/erk kinase kinase 1 (mekk1)
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917747/
https://www.ncbi.nlm.nih.gov/pubmed/35279218
http://dx.doi.org/10.1186/s13046-022-02312-6
work_keys_str_mv AT zhaolin correctiontomir302abcdcooperativelysensitizesbreastcancercellstoadriamycinviasuppressingpglycoproteinpgpbytargetingmaperkkinasekinase1mekk1
AT wangyan correctiontomir302abcdcooperativelysensitizesbreastcancercellstoadriamycinviasuppressingpglycoproteinpgpbytargetingmaperkkinasekinase1mekk1
AT jianglongyang correctiontomir302abcdcooperativelysensitizesbreastcancercellstoadriamycinviasuppressingpglycoproteinpgpbytargetingmaperkkinasekinase1mekk1
AT hemiao correctiontomir302abcdcooperativelysensitizesbreastcancercellstoadriamycinviasuppressingpglycoproteinpgpbytargetingmaperkkinasekinase1mekk1
AT baixuefeng correctiontomir302abcdcooperativelysensitizesbreastcancercellstoadriamycinviasuppressingpglycoproteinpgpbytargetingmaperkkinasekinase1mekk1
AT yulifeng correctiontomir302abcdcooperativelysensitizesbreastcancercellstoadriamycinviasuppressingpglycoproteinpgpbytargetingmaperkkinasekinase1mekk1
AT weiminjie correctiontomir302abcdcooperativelysensitizesbreastcancercellstoadriamycinviasuppressingpglycoproteinpgpbytargetingmaperkkinasekinase1mekk1

Ejemplares similares